قالب:موسعات الأوعية مثبطات الودي - تاريخ المراجعة

أسيل سيوف في 08:22، 16 نوفمبر 2013

2013-11-16T08:22:33Z

→ مراجعة أقدم		مراجعة 08:22، 16 نوفمبر 2013
سطر 85:		سطر 85:
	}}		}}

	\| group4 = Other agonist		\| group4 = Other [[agonist]]
	\| list4 = [[Fenoldopam]]		\| list4 = [[Fenoldopam]]

	}}

	~~\| group5 =~~
	~~\| list5 = {{PharmNavFootnote}}~~

	}}<noinclude>		}}<noinclude>
	[[تصنيف:جداول تصفح الأدوية\|{{PAGENAME}}]]		[[تصنيف:جداول تصفح الأدوية\|{{PAGENAME}}]]
	</noinclude>		</noinclude>

أسيل سيوف في 08:10، 16 نوفمبر 2013

2013-11-16T08:10:06Z

→ مراجعة أقدم		مراجعة 08:10، 16 نوفمبر 2013
سطر 85:		سطر 85:
	}}		}}

			\| group4 = Other agonist
			\| list4 = [[Fenoldopam]]

	\| ~~group4~~ =		}}
	\| ~~list4~~ = {{PharmNavFootnote}}
			\| group5 =
			\| list5 = {{PharmNavFootnote}}

	}}<noinclude>		}}<noinclude>
	[[تصنيف:جداول تصفح الأدوية\|{{PAGENAME}}]]		[[تصنيف:جداول تصفح الأدوية\|{{PAGENAME}}]]
	</noinclude>		</noinclude>

كنان الطرح في 06:24، 1 نوفمبر 2013

2013-11-01T06:24:30Z

→ مراجعة أقدم		مراجعة 06:24، 1 نوفمبر 2013
سطر 1:		سطر 1:
	{{Navbox		{{Navbox
	\| name = أدوية مضادة لضغط الدم المرتفع		\| name = أدوية مضادة لضغط الدم المرتفع
	\| title = [[Sympatholytic]] (and closely related) [[antihypertensive]]s ([[ATC code C02\|C02]])		\| title = [[Sympatholytic]] (and closely related) [[antihypertensive]]s ([[ATC code C02\|C02]]) [https://en.wikipedia.org/wiki/Template:Sympatholytic_antihypertensives القالب الأجنبي]
	\|listclass = hlist		\|listclass = hlist
	\| groupstyle = background:MistyRose;		\| groupstyle = background:MistyRose;

كنان الطرح: نقل كنان الطرح صفحة قالب:أدوية مضادة لضغط الدم المرتفع إلى قالب:موسعات الأوعية مثبطات الودي

2013-05-27T10:34:37Z

نقل كنان الطرح صفحة قالب:أدوية مضادة لضغط الدم المرتفع إلى قالب:موسعات الأوعية مثبطات الودي

→ مراجعة أقدم	مراجعة 10:34، 27 مايو 2013
(لا فرق)

أسيل سيوف في 12:45، 22 مارس 2013

2013-03-22T12:45:54Z

→ مراجعة أقدم		مراجعة 12:45، 22 مارس 2013
سطر 2:		سطر 2:
	\| name = أدوية مضادة لضغط الدم المرتفع		\| name = أدوية مضادة لضغط الدم المرتفع
	\| title = [[Sympatholytic]] (and closely related) [[antihypertensive]]s ([[ATC code C02\|C02]])		\| title = [[Sympatholytic]] (and closely related) [[antihypertensive]]s ([[ATC code C02\|C02]])
			\|listclass = hlist
	\| groupstyle = background:MistyRose;		\| groupstyle = background:MistyRose;

سطر 13:		سطر 14:

	\| group1 = [[Alpha-adrenergic agonist#.CE.B12 agonists\|α<sub>2</sub> agonist]]		\| group1 = [[Alpha-adrenergic agonist#.CE.B12 agonists\|α<sub>2</sub> agonist]]
	\| list1 = [[Clonidine]] • [[Guanfacine]] • [[Methyldopa]] #		\| list1 =
			[[Clonidine]] * [[Guanfacine]] * [[Methyldopa]] #

	\| group2 = Adrenergic release inhibitors		\| group2 = Adrenergic release inhibitors
	\| list2 = [[Bethanidine]] • [[Bretylium]] • [[Debrisoquine]] • [[Guanadrel]] • [[Guanazodine]] • [[Guanethidine]] • [[Guanoclor]] • [[Guanoxan]] • [[Guanazodine]] • [[Guanoxabenz]] • [[Guanoxan]]		\| list2 =
			[[Bethanidine]] * [[Bretylium]] * [[Debrisoquine]] * [[Guanadrel]] * [[Guanazodine]] * [[Guanethidine]] * [[Guanoclor]] * [[Guanoxan]] * [[Guanazodine]] * [[Guanoxabenz]] * [[Guanoxan]]

	\| group3 = [[Imidazoline receptor]] agonist		\| group3 = [[Imidazoline receptor]] agonist
	\| list3 = [[Moxonidine]] • [[Rilmenidine]]		\| list3 =
			[[Moxonidine]] * [[Rilmenidine]]

	\| group4 = [[Ganglionic blocker\|Ganglion-blocking]]/[[nicotinic antagonist]]		\| group4 = [[Ganglionic blocker\|Ganglion-blocking]]/[[nicotinic antagonist]]
	\| list4 = [[Mecamylamine]] • [[Trimethaphan]]		\| list4 =
			[[Mecamylamine]] * [[Pentolinium]] * [[Trimetaphan camsilate\|Trimethaphan]]

	}}		}}
سطر 35:		سطر 40:

	\| group1 = [[Monoamine oxidase inhibitor\|MAOI]]		\| group1 = [[Monoamine oxidase inhibitor\|MAOI]]
	\| list1 = [[Pargyline]]		\| list1 =
			[[Pargyline]]

	\| group2 = [[Adrenergic uptake inhibitor]]		\| group2 = [[Norepinephrine reuptake inhibitor\|Adrenergic uptake inhibitor]]
	\| list2 = [[Rescinnamine]] • [[Reserpine]]		\| list2 =
			[[Bietaserpine]] * [[Deserpidine]] * [[Methoserpidine]] * [[Rescinnamine]] * [[Reserpine]]

	\| group3 = [[Tyrosine hydroxylase inhibitor]]		\| group3 = [[Tyrosine hydroxylase inhibitor]]
	\| list3 = [[Metirosine]]		\| list3 =
			[[Metirosine]]

	}}		}}
سطر 50:		سطر 58:

	\| group1 = [[Alpha-1 blocker\|α<sub>1</sub> blocker]]s		\| group1 = [[Alpha-1 blocker\|α<sub>1</sub> blocker]]s
	\| list1 = [[Prazosin]] • [[Indoramin]] • [[Trimazosin]] • [[Doxazosin]] • [[Urapidil]]		\| list1 =
			[[Prazosin]] * [[Indoramin]] * [[Trimazosin]] * [[Doxazosin]] * [[Urapidil]]

	\| group2 = Non-selective α blocker		\| group2 = Non-selective α blocker
	\| list2 = [[Phentolamine]]		\| list2 =
			[[Phentolamine]]

	}}		}}
سطر 64:		سطر 74:
	\| list2 = {{Navbox subgroup		\| list2 = {{Navbox subgroup
	\| groupstyle = background:MistyRose;		\| groupstyle = background:MistyRose;


	\| group2 = [[Serotonin antagonist]]		\| group2 = [[Serotonin antagonist]]
	\| list2 = [[Ketanserin]]		\| list2 =
			[[Ketanserin]] * [[Lidanserin]]

	\| group3 = [[Endothelin receptor antagonist\|Endothelin antagonist]] (for [[Pulmonary hypertension\|PH]])		\| group3 = [[Endothelin receptor antagonist\|Endothelin antagonist]] (for [[Pulmonary hypertension\|PH]])
	\| list3 = ''dual'' ([[Bosentan]]) • ''selective'' ([[Ambrisentan]], [[Sitaxentan]])		\| list3 =
			''dual'' ([[Bosentan]]) * ''selective'' ([[Ambrisentan]], [[Sitaxentan]])

	}}		}}

إدارة الموسوعة: أنشأ الصفحة ب'{{Navbox | name = أدوية مضادة لضغط الدم المرتفع | title = Sympatholytic (and closely related) antihypertensives (C02) | g...'

2011-08-16T19:48:02Z

أنشأ الصفحة ب'{{Navbox | name = أدوية مضادة لضغط الدم المرتفع | title = Sympatholytic (and closely related) antihypertensives (C02) | g...'

صفحة جديدة

{{Navbox
| name = أدوية مضادة لضغط الدم المرتفع
| title = [[Sympatholytic]] (and closely related) [[antihypertensive]]s ([[ATC code C02|C02]])
| groupstyle = background:MistyRose;

| group1 = [[Sympatholytic]]s (antagonize [[Adrenergic_receptor#.CE.B1_receptors|α-adrenergic]] [[vasoconstriction]])
| list1 = {{Navbox subgroup
| groupstyle = background:MistyRose;

| group1 = Central
| list1 = {{Navbox subgroup
| groupstyle = background-color: MistyRose;

| group1 = [[Alpha-adrenergic agonist#.CE.B12 agonists|α2 agonist]]
| list1 = [[Clonidine]] • [[Guanfacine]] • [[Methyldopa]] #

| group2 = Adrenergic release inhibitors
| list2 = [[Bethanidine]] • [[Bretylium]] • [[Debrisoquine]] • [[Guanadrel]] • [[Guanazodine]] • [[Guanethidine]] • [[Guanoclor]] • [[Guanoxan]] • [[Guanazodine]] • [[Guanoxabenz]] • [[Guanoxan]]

| group3 = [[Imidazoline receptor]] agonist
| list3 = [[Moxonidine]] • [[Rilmenidine]]

| group4 = [[Ganglionic blocker|Ganglion-blocking]]/[[nicotinic antagonist]]
| list4 = [[Mecamylamine]] • [[Trimethaphan]]

}}

| group2 = Peripheral
| list2 = {{Navbox subgroup
| groupstyle = background-color: MistyRose;

| group1 = Indirect
| list1 = {{Navbox subgroup
| groupstyle = background-color: MistyRose;

| group1 = [[Monoamine oxidase inhibitor|MAOI]]
| list1 = [[Pargyline]]

| group2 = [[Adrenergic uptake inhibitor]]
| list2 = [[Rescinnamine]] • [[Reserpine]]

| group3 = [[Tyrosine hydroxylase inhibitor]]
| list3 = [[Metirosine]]

}}

| group2 = Direct
| list2 = {{Navbox subgroup
| groupstyle = background-color: MistyRose;

| group1 = [[Alpha-1 blocker|α1 blocker]]s
| list1 = [[Prazosin]] • [[Indoramin]] • [[Trimazosin]] • [[Doxazosin]] • [[Urapidil]]

| group2 = Non-selective α blocker
| list2 = [[Phentolamine]]

}}

}}

}}

| group2 = Other [[Receptor antagonist|antagonist]]s
| list2 = {{Navbox subgroup
| groupstyle = background:MistyRose;

| group2 = [[Serotonin antagonist]]
| list2 = [[Ketanserin]]

| group3 = [[Endothelin receptor antagonist|Endothelin antagonist]] (for [[Pulmonary hypertension|PH]])
| list3 = ''dual'' ([[Bosentan]]) • ''selective'' ([[Ambrisentan]], [[Sitaxentan]])

}}

| group4 =
| list4 = {{PharmNavFootnote}}

}}<noinclude>
[[تصنيف:جداول تصفح الأدوية|{{PAGENAME}}]]
</noinclude>